Mycoplasma contamination is a common challenge in cell culture environments that can remain undetected for months, affecting cell characteristics and compromising laboratory assays and recombinant drug production processes. Since conventional antibiotics such as penicillin and streptomycin cannot eliminate mycoplasma, continuous monitoring is essential, especially for newly acquired cell lines and before cell banking. LivoGen Pharmed’s Myco-Qtech Kit enables rapid and accurate detection of contamination from more than 60 mycoplasma species using Real-Time PCR technology, supporting reliable cell culture quality control.